Asana, Inc.
ASANNYSETechnology · Services-Prepackaged Software · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | |
|---|---|---|---|---|---|---|
| Revenue | $790.8M | $723.9M | $652.5M | $547.2M | $378.4M | $227.0M |
| Operating income | −$197.3M | −$266.7M | −$270.0M | −$407.8M | −$265.2M | −$175.6M |
| Net income | −$189.0M | −$255.5M | −$257.0M | −$407.8M | −$288.3M | −$211.7M |
| Total assets | $844.1M | $891.4M | $962.0M | $955.0M | $707.0M | $731.1M |
| Total liabilities | $690.0M | $663.9M | $635.6M | $598.4M | $503.2M | $743.9M |
| Equity | $154.1M | $227.5M | $326.4M | $356.6M | $203.8M | −$12.8M |
| EPS (diluted) | $-0.80 | $-1.11 | $-1.17 | $-2.04 | $-1.63 | $-1.99 |
| Shares out. | 236.8M | 229.5M | 224.7M | 214.3M | 188.3M | 161.5M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2026- Operating margin
- −25.0%
- Net margin
- −23.9%
- Return on equity
- −122.6%
- Return on assets
- −22.4%
- Return on capital (ROCE)
- −57.5%
- Liabilities / assets
- 81.7%
- Debt / equity
- 4.48×
- Book value / share
- $0.65
- Revenue growth (YoY)
- 9.2%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2026- Altman Z″ (distress)
- -8.92distress
- Accruals / assets
- −33.1%clean
- Beneish M-Score
- -3.94normal
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 3 warning● 3 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- High leverage (liabilities > 70% of assets)
- Revenue is growing year-over-year
- Positive operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Rosenstein JustinPassive (13G)May 15, 2026
- Vanguard Portfolio Management LlcPassive (13G)Apr 28, 2026
- Vanguard Group IncPassive (13G)Mar 26, 2026
- Moskovitz Dustin A.Activist (13D)Aug 15, 2025
- Voya Financial, Inc.Passive (13G)Aug 11, 2025
- Allianz Global Investors GmbhPassive (13G)Apr 28, 2025
- Blackrock, Inc.Passive (13G)Apr 24, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Megji AzizOfficer — Chief Financial Officer | May 6, 2026 | Grant | 585,775 | $0.00 |
| Colendich Katie MarieOfficer — GC, Corporate Secretary | May 6, 2026 | Grant | 98,200 | $0.00 |
| D'Angelo AdamDirector | May 1, 2026 | Grant | 1,186 | $0.00 |
| Norrington Lorrie MDirector | May 1, 2026 | Grant | 2,323 | $0.00 |
| Anderson-Copperman KristaDirector | May 1, 2026 | Grant | 2,056 | $0.00 |
| Cohler MattDirector | May 1, 2026 | Grant | 1,335 | $0.00 |
| Rosenstein JustinDirector | Mar 31, 2026 | Conversion | 6.3M | $0.00 |
| Megji AzizOfficer — Chief Financial Officer | Mar 27, 2026 | Sell | 30,650 | $6.10 |
| Colendich Katie MarieOfficer — GC, Corporate Secretary | Mar 24, 2026 | Sell | 1,500 | $6.39 |
| Parekh Sonalee ElizabethOfficer — Chief Financial Officer | Mar 23, 2026 | Sell | 18,717 | $6.62 |
| Colendich Katie MarieOfficer — GC, Corporate Secretary | Mar 20, 2026 | Sell | 3,575 | $6.65 |
| Parekh Sonalee ElizabethOfficer — Chief Financial Officer | Mar 20, 2026 | Sell | 34,151 | $6.65 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 32.7M | 4.5 | +7.5% |
| Apr 30, 2026 | 30.5M | 4.8 | -4.1% |
| Apr 15, 2026 | 31.8M | 4.2 | +3.2% |
| Mar 31, 2026 | 30.8M | 5.7 | +18.0% |
| Mar 13, 2026 | 26.1M | 4.0 | +1.5% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operationsMay 28, 2026
- Director / officer changeApr 20, 2026
- Director / officer changeMar 13, 2026
- Results of operations · Other material eventMar 2, 2026
- Director / officer changeMar 2, 2026
- Results of operations · Director / officer changeDec 2, 2025
- Material impairmentSep 9, 2025
- Results of operationsSep 3, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (2)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.